In other studies, necrotic cell-derived PGE2 has been proposed to be an inhibitory DAMP that tempers the immunostimulatory effect of dead cells31, and caspase 3-mediated PGE2 release by dying cancer cells has been implicated in cancer cell repopulation post-cytotoxic therapy32,33. This evidence concerns the gene CASP3 and cancer.